Atovaquone and ELQ-300 combination therapy as a novel dual-site cytochrome bc1 inhibition strategy for malaria

Allison M. Stickles, Martin J. Smilkstein, Joanne M. Morrisey, Yuexin Li, Isaac P. Forquer, Jane X. Kelly, Sovitj Pou, Rolf W. Winter, Aaron Nilsen, Akhil B. Vaidya, Michael K. Riscoe

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Atovaquone and ELQ-300 combination therapy as a novel dual-site cytochrome bc<sub>1</sub> inhibition strategy for malaria'. Together they form a unique fingerprint.

Medicine & Life Sciences